Why the study?
Identifying predictors of major cardiovascular events remains challenging, particularly in early and stable cardiovascular diseases.
Does TAPSE predict major cardiovascular events and all-cause mortality in stable patients with cardiovascular risk factors?
Does TAPSE predict major cardiovascular events and all-cause mortality in stable patients with cardiovascular risk factors?
TAPSE is a strong independent predictor of major cardiovascular events and all-cause mortality in patients with early and stable cardiovascular disease.
TAPSE independently predicts MACEs and mortality in stable patients; leaves open whether routine RV assessment improves risk stratification or outcomes.
The identification of predictors of major cardiovascular events (MACES) represents a big challenge, especially in early and stable cardiovascular diseases. This prospective study comparatively evaluated the prognostic importance of left ventricular (LV) and right ventricular (RV) systolic and diastolic function, pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) in a stable patient's cohort with cardiovascular risk factors. The LV ejection fraction, mitral annular plane systolic excursion (MAPSE), tricuspid annular plane systolic excursion (TAPSE), functional mitral regurgitation (FMR), doppler tissue imaging of mitral and tricuspid annulus with systolic and diastolic peaks estimation, tricuspid regurgitation velocity (TRV), pulmonary velocity outflow time integral (PVTI), mean pulmonary artery pressure (MPAP) and PVR were estimated at enrollment. During the follow-up, MACES and all-cause mortality were recorded. 369 subjects with or without previous MACES were enrolled. Bivariate analysis revealed LVEF, TAPSE, MPAP, TRV, PVR, LV diastolic function, and FMR were associated with the endpoints. When computing the influence of covariates to the primary endpoint (all-cause mortality and MACES) through Cox analysis, only LV diastolic function and TAPSE entered the final model; for the secondary endpoint (MACES) only TAPSE entered. TAPSE was able to predict MACES and all-cause mortality in early and stable cardiovascular diseases. The use of TAPSE should be implemented.
No takes yet. Share an insight, caveat, or question.
Giovanardi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: